Yellowstone Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$386K Sell
3,696
-1,452
-28% -$164K 0.22% 106
2017
Q3
$751K Buy
+5,148
New +$701K 0.39% 63
2016
Q3
$1.48M Sell
14,145
-1,296
-8% -$140K 0.54% 44
2016
Q2
$1.52M Sell
15,441
-511
-3% -$52.9K 0.66% 37
2016
Q1
$1.6M Sell
15,952
-17
-0.1% -$1.75K 0.69% 33
2015
Q4
$1.91M Sell
15,969
-142
-0.9% -$16.4K 0.86% 23
2015
Q3
$1.74M Buy
16,111
+1,302
+9% +$162K 0.82% 24
2015
Q2
$1.71M Sell
14,809
-1,610
-10% -$184K 0.78% 23
2015
Q1
$1.89M Buy
16,419
+588
+4% +$70.3K 0.95% 23
2014
Q4
$1.77M Sell
15,831
-1,092
-6% -$115K 0.95% 22
2014
Q3
$1.6M Sell
16,923
-2,694
-14% -$243K 0.91% 23
2014
Q2
$1.69M Buy
19,617
+3,741
+24% +$284K 0.98% 21
2014
Q1
$1.11M Sell
15,876
-680
-4% -$53.9K 0.7% 27
2013
Q4
$1.4M Buy
+16,556
New +$1.31M 0.9% 23

Other funds holding CELG

Yellowstone Partners's CELG Position: Q4 2017 in Review

Yellowstone Partners reduced its Celgene Corp (CELG) stake by 28% in Q4 2017, selling an estimated $164K and leaving 3,696 shares worth $386K. The position accounts for 0.22% of the portfolio, ranked #106.

Yellowstone Partners first reported a position in CELG in Q4 2013 and has held it in 14 quarters since. The position peaked at $1.91M in Q4 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Yellowstone Partners held 3,696 shares of Celgene Corp worth $386K as of Q4 2017.
  • Yellowstone Partners sold 1,452 Celgene Corp shares in Q4 2017, an estimated $164K.
  • Celgene Corp made up 0.22% of Yellowstone Partners's portfolio in Q4 2017, its #106 holding.
  • Yellowstone Partners first reported a position in Celgene Corp in Q4 2013 and has held it in 14 quarters since.
  • Yellowstone Partners's Celgene Corp position peaked at $1.91M in Q4 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Yellowstone Partners's 13F filing for Q4 2017, filed 24 Jan 2018.